Opportunity Information: Apply for W81XWH 11 PCRP IDA
Apply for W81XWH 11 PCRP IDA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD FY11 Prostate Cancer Idea Development Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Apr 22, 2011 and posted on Apr 21, 2011.
- Applicants must submit their applications by Aug 23, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $31,800,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 63 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD FY11 Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) is a Department of the Army funding opportunity intended to spark fresh, high-impact ideas in prostate cancer research. It is built to support innovative, sometimes higher-risk concepts that could meaningfully reduce death and suffering from prostate cancer, as long as the proposal is grounded in a solid scientific rationale supported by logical reasoning and/or a strong critical analysis of existing literature. The IDA mechanism has a long track record within the PCRP, first launched in FY97, and by FY11 it had attracted about 5,700 applications, with 971 recommended for funding, reflecting both strong competition and an established funding pathway for novel approaches.
A central expectation is innovation: applicants are encouraged to propose new directions, methods, hypotheses, or technologies that could move the field forward. Preliminary data can strengthen an application, but it is not required, which is meant to lower the barrier for truly new ideas that are not yet heavily developed. If preliminary results are included, they are expected to come from the Principal Investigator (PI) or members of the collaborating research team, reinforcing that the proposed work is feasible within the team that will carry it out.
The program strongly encourages applicants to align their projects with one of the FY11 PCRP overarching challenges. The PCRP is open to a broad range of research across the spectrum from basic science through clinical research. If a project does not directly address one of the overarching challenges, the application is expected to clearly justify why the work still tackles a critical gap or urgent need in prostate cancer research and/or patient care. For proposals that are primarily population-based studies, the announcement points investigators toward a different mechanism, the FY11 PCRP Population Based Research Award, suggesting that the IDA is not the preferred route for work that is mainly epidemiologic or population-level in nature.
Human subjects research is allowed under this award, but only in forms that do not meet the definition of a clinical trial. The announcement uses a relatively standard definition: a clinical trial involves prospective enrollment of human subjects where an intervention (such as a drug, device, biologic, surgery, rehabilitation approach, behavioral intervention, or similar) is tested for measurable outcomes related to safety, effectiveness, efficacy, or other exploratory endpoints that directly result from the intervention. Investigators who want to run a clinical trial are directed instead to the FY11 PCRP Clinical Trial Award. The program also references a Human Subject Resource Document available through the CDMRP site to help applicants determine where their proposed human research falls within these boundaries.
A notable feature of the FY11 IDA is the New Investigator Option, which is designed to encourage participation by early-career researchers who are beginning faculty appointments or developing independent research trajectories. Under this option, New Investigator applications are reviewed in a separate pool from Established Investigator applications during both peer and programmatic review, so early-career applicants are not directly competing against long-established labs in the same review group. Even so, the program strongly encourages New Investigators to collaborate with experienced prostate cancer researchers or other experts whose publication and funding records demonstrate relevant capability. Applicants are responsible for clearly explaining how the collaboration strengthens the project, fills gaps in the PI’s expertise, and improves the overall ability of the team to answer the research question.
Administratively, this opportunity (Funding Opportunity Number W81XWH-11-PCRP-IDA) was offered as a discretionary award mechanism using grants and cooperative agreements under CFDA 12.420 (Military Medical Research and Development). The estimated total funding was $31.8 million with an expected 63 awards, and it did not require cost sharing or matching. Eligibility was described as unrestricted (open to any type of entity, subject to any clarifications in the full announcement). The opportunity was posted April 21, 2011, with an application closing date of August 23, 2011, and an archive date of September 22, 2011. For access issues or assistance with the full announcement, applicants were directed to the CDMRP Help Desk at 301-682-5507.
FAQs: DoD FY11 Prostate Cancer Research Program (PCRP) Idea Development Award (IDA)
What is the FY11 PCRP Idea Development Award (IDA)?
The FY11 PCRP Idea Development Award (IDA) is a Department of the Army funding opportunity under the DoD Prostate Cancer Research Program (PCRP) intended to spark fresh, high-impact ideas in prostate cancer research. It is designed to support innovative, sometimes higher-risk concepts that could meaningfully reduce death and suffering from prostate cancer, as long as the proposal is grounded in a solid scientific rationale supported by logical reasoning and/or a strong critical analysis of existing literature.
What is the official funding opportunity number (FON) for this award?
The Funding Opportunity Number is W81XWH-11-PCRP-IDA.
Which federal program and CFDA number is associated with this opportunity?
This opportunity was offered under CFDA 12.420, Military Medical Research and Development.
What types of research does the IDA support?
The PCRP is open to a broad range of prostate cancer research across the spectrum from basic science through clinical research, as long as the work fits the IDA intent (idea development with strong innovation) and remains grounded in solid scientific rationale.
Is innovation required, or just encouraged?
Innovation is a central expectation of the IDA. Applicants are encouraged to propose new directions, methods, hypotheses, or technologies that could move the field forward.
Do I need preliminary data to apply?
No. Preliminary data can strengthen an application, but it is not required. This is meant to lower the barrier for truly new ideas that are not yet heavily developed.
If I include preliminary data, are there requirements about where it comes from?
Yes. If preliminary results are included, they are expected to come from the Principal Investigator (PI) or members of the collaborating research team, supporting the feasibility of doing the proposed work with the team named in the application.
Does the program want projects to align with specific PCRP priorities or challenges?
Yes. Applicants are strongly encouraged to align their projects with one of the FY11 PCRP overarching challenges.
What if my project does not directly address one of the overarching challenges?
If a project does not directly address one of the overarching challenges, the application is expected to clearly justify why the work still tackles a critical gap or urgent need in prostate cancer research and/or patient care.
Is population-based research appropriate for the IDA?
If a proposal is primarily a population-based study, the announcement points investigators to a different mechanism: the FY11 PCRP Population Based Research Award. This suggests the IDA is not the preferred route for work that is mainly epidemiologic or population-level in nature.
Is human subjects research allowed under the IDA?
Yes. Human subjects research is allowed under this award, but only in forms that do not meet the definition of a clinical trial.
Are clinical trials allowed under this funding opportunity?
No. Projects that meet the definition of a clinical trial are not supported under the IDA. Investigators who want to run a clinical trial are directed instead to the FY11 PCRP Clinical Trial Award.
How does the announcement define a clinical trial?
A clinical trial is described as prospective enrollment of human subjects where an intervention is tested for measurable outcomes related to safety, effectiveness, efficacy, or other exploratory endpoints that directly result from the intervention. Interventions can include a drug, device, biologic, surgery, rehabilitation approach, behavioral intervention, or similar.
Where can applicants find guidance to determine whether their human research is a clinical trial?
The program references a Human Subject Resource Document available through the CDMRP site to help applicants determine where their proposed human research falls within the stated boundaries.
What is the New Investigator Option?
The FY11 IDA includes a New Investigator Option designed to encourage participation by early-career researchers who are beginning faculty appointments or developing independent research trajectories.
How are New Investigator applications reviewed?
New Investigator applications are reviewed in a separate pool from Established Investigator applications during both peer and programmatic review. This means early-career applicants are not directly competing against long-established labs in the same review group.
Are New Investigators expected to have collaborators?
The program strongly encourages New Investigators to collaborate with experienced prostate cancer researchers or other experts whose publication and funding records demonstrate relevant capability.
What do applicants need to explain about collaborations?
Applicants are responsible for clearly explaining how the collaboration strengthens the project, fills gaps in the PI's expertise, and improves the overall ability of the team to answer the research question.
What funding instruments were used for this opportunity?
This opportunity was offered as a discretionary award mechanism using grants and cooperative agreements.
How much total funding was estimated for the FY11 IDA?
The estimated total funding was $31.8 million.
How many awards were expected?
The opportunity anticipated approximately 63 awards.
Is cost sharing or matching required?
No. The announcement stated that cost sharing or matching was not required.
Who was eligible to apply?
Eligibility was described as unrestricted (open to any type of entity), subject to any clarifications in the full announcement.
When was the opportunity posted, and what were the key dates?
The opportunity was posted on April 21, 2011. The application closing date was August 23, 2011. The archive date was September 22, 2011.
How competitive has this award mechanism been historically?
The IDA mechanism has a long track record within the PCRP, first launched in FY97. By FY11, it had attracted about 5,700 applications, with 971 recommended for funding, reflecting strong competition and an established pathway for novel approaches.
Where can applicants get help accessing the full announcement or resolving access issues?
Applicants were directed to the CDMRP Help Desk at 301-682-5507 for access issues or assistance with the full announcement.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DoD FY11 Prostate Cancer Synergistic Idea Development Award
Previous opportunity: DoD FY11 Prostate Cancer Exploration Hypothesis Development Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 11 PCRP IDA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 11 PCRP IDA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD FY11 Prostate Cancer Synergistic Idea Development Award Apply for W81XWH 11 PCRP SIDA Funding Number: W81XWH 11 PCRP SIDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Tribal Colleges and Universities Program Apply for 11 538 Funding Number: 11 538 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $2,500,000 |
| Software Infrastructure for Sustained Innovation Apply for 11 539 Funding Number: 11 539 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $5,000,000 |
| Research Training Groups in the Mathematical Sciences Apply for 11 540 Funding Number: 11 540 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $500,000 |
| DoD Bone Marrow Failure Idea Award Apply for W81XWH 11 BMFRP IA Funding Number: W81XWH 11 BMFRP IA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Bone Marrow Failure Resource Development Award Apply for W81XWH 11 BMFRP RDA Funding Number: W81XWH 11 BMFRP RDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Bone Marrow Failure Postdoctoral Fellowship Award Apply for W81XWH 11 BMFRP POSTDOC Funding Number: W81XWH 11 BMFRP POSTDOC Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Peer Reviewed Medical Discovery Award Apply for W81XWH 11 PRMRP DA Funding Number: W81XWH 11 PRMRP DA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Science and Technology Fellow(s) needed to help agency obtain technical expertise to contribute to more effective application of science and technology in the international development and foreign affairs activities of the U.S. government. Apply for MCC 11 9036 RFA 64 Funding Number: MCC 11 9036 RFA 64 Agency: Millennium Challenge Corporation Category: Science and Technology and other Research and Development Funding Amount: $2,100,000 |
| DoD Peer Reviewed Medical Technology/Therapeutic Development Award Apply for W81XWH 11 PRMRP TTDA Funding Number: W81XWH 11 PRMRP TTDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Peer Reviewed Medical Clinical Trial Award Apply for W81XWH 11 PRMRP CTA Funding Number: W81XWH 11 PRMRP CTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Peer Reviewed Medical Investigator Initiated Research Award Apply for W81XWH 11 PRMRP IIRA Funding Number: W81XWH 11 PRMRP IIRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Continental Dynamics Apply for 04 512 Funding Number: 04 512 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Mentoring Through Critical Transition Points in the Mathematical Sciences Apply for 11 542 Funding Number: 11 542 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $2,500,000 |
| Mathematical Sciences Postdoctoral Research Fellowships Apply for 11 541 Funding Number: 11 541 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Ceramics Apply for PD 11 1774 Funding Number: PD 11 1774 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD FY11 Multiple Sclerosis Idea Award Apply for W81XWH 11 MSRP IA Funding Number: W81XWH 11 MSRP IA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Air Force Fiscal Year 2012 Young Investigator Research Program Apply for BAA AFOSR 2011 05 Funding Number: BAA AFOSR 2011 05 Agency: Air Force Office of Scientific Research Category: Science and Technology and other Research and Development Funding Amount: $600,000 |
| Cooperative Ecosystem Studies Unit, Californian CESU Apply for G11AS20032 Funding Number: G11AS20032 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Californian CESU Apply for G11AS20030 Funding Number: G11AS20030 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 11 PCRP IDA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.